Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial.

Saved in:
Bibliographic Details
Title: Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial.
Authors: Alexander S; Division of Pediatric Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. Electronic address: sarah.alexander@sickkids.ca., Aupérin A; Biostatistics and Epidemiology Office, Gustave Roussy, INSERM U1018 Oncostat, Labelled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France., Bomken S; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; The Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Csóka M; Department of Pediatrics, Semmelweis University, Budapest, Hungary., Kazanowska B; Department of Pediatric Bone Marrow Transplantation, Oncology, and Hematology, Wroclaw Medical University, Wroclaw, Poland., Chiang AK; Department of Pediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China., Andres M; Department of Pediatric Hematology and Oncology, University of Valencia, Valencia, Spain., Uyttebroeck A; Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium., Burke GAA; Department of Paediatric Haematology, Oncology, and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Zsiros J; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Pillon M; Maternal and Child Health Department, Padova University, Padova, Italy., Bollard CM; Center for Cancer and Immunology Research, Children's National Hospital and The George Washington University, Washington, DC, USA., Mussolin L; Maternal and Child Health Department, Padova University, Padova, Italy; Unit of Oncohematology, Stem Cell Transplant and Gene Therapy, Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy., Verdu-Amoros J; Department of Pediatric Hematology and Oncology, University Hospital Valencia, Valencia, Spain., Neven B; Department of Pediatric Immunology, Hematology and Rheumatology, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Unit of Pediatric Immunology, Haematology and Rheumatology, Paris Cité University, Imagine Institute, Paris, France., Barkauskas DA; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, California, LA, USA., Wheatley K; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Patte C; Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Gross TG; Center for Cancer and Blood Disorders, Children's Hospital of Colorado, Aurora, CO, USA., Minard-Colin V; Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Corporate Authors: Children's Oncology Group, European Intergroup for Childhood Non-Hodgkin's Lymphoma
Source: The Lancet. Haematology [Lancet Haematol] 2023 Jun; Vol. 10 (6), pp. e445-e457. Date of Electronic Publication: 2023 Apr 21.
Publication Type: Randomized Controlled Trial; Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-3026
DOI:10.1016/S2352-3026(23)00062-5